FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1756-1757 June 16, 1994 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rosell, R. PubMed Citation

To the Editor: We are concerned about several aspects of the study by Rosell et al. (Jan. 20 issue)¹. The title is incorrect and misleading: the trial did not compare preoperative chemotherapy plus surgery with surgery alone; the trial compared preoperative chemotherapy plus surgery plus radiotherapy with surgery plus radiotherapy.

The rates of survival and disease-free survival were extremely poor in the surgery-plus-radiotherapy group. These rates would be expected among patients with metastatic non-small-cell lung cancer but are inferior to what would be expected in patients with resectable stage III disease. In several randomized trials, reviewed by Van Houtte,² . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Depierre, A., Milleron, B., Moro-Sibilot, D., Chevret, S., Quoix, E., Lebeau, B., Braun, D., Breton, J.-L., Lemarie, E., Gouva, S., Paillot, N., Brechot, J.-M., Janicot, H., Lebas, F.-X., Terrioux, P., Clavier, J., Foucher, P., Monchatre, M., Coetmeur, D., Level, M.-C., Leclerc, P., Blanchon, F., Rodier, J.-M., Thiberville, L., Villeneuve, A., Westeel, V., Chastang, C. (2002). Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung Cancer. JCO 20: 247-253 [Abstract] [Full Text]